Sakda Waraasawapati
Khon Kaen, 40002, Thailand
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Detection of Serum Tumor-Associated Glycobiomarker for Meningioma Using Dolichos biflorus Agglutinin.
Journal: Journal of proteome research
Published: November 18, 2025
Serum N-Glycomics with Nano-LC-QToF LC-MS/MS Reveals N-Glycan Biomarkers for Glioblastoma, Meningioma, and High-Grade Meningioma.
Journal: Journal of proteome research
Published: February 05, 2025
High cyclic GMP-AMP synthase and stimulator of interferon genes in cholangiocarcinoma suggest their potential as targets for treatment.
Journal: PeerJ
Published: October 15, 2024
Facilitating cholangiocarcinoma inhibition by targeting CD47.
Journal: Experimental and molecular pathology
Published: November 12, 2023
Corrigendum to "Curcumin-loaded nanocomplexes: Acute and chronic toxicity studies in mice and hamsters" [Toxicol. Rep. 8 (2021) 1346-1357/ S221475002100127X].
Journal: Toxicology reports
Published: July 03, 2023
Differentiation between germinoma and other pineal region tumors using diffusion-and susceptibility-weighted MRI.
Journal: European journal of radiology
Published: July 04, 2022
Curcumin-loaded nanocomplexes ameliorate the severity of nonalcoholic steatohepatitis in hamsters infected with Opisthorchis viverrini.
Journal: PloS one
Published: April 22, 2022
Retraction Note to: FOXM1 modulates 5-fluorouracil sensitivity in cholangiocarcinoma through thymidylate synthase (TYMS): implications of FOXM1-TYMS axis uncoupling in 5-FU resistance.
Journal: Cell death & disease
Published: May 26, 2021
Curcumin-loaded nanocomplexes: Acute and chronic toxicity studies in mice and hamsters.
Journal: Toxicology reports
Published: April 18, 2021
A Novel Serum Glycobiomarker for Diagnosis and Prognosis of Cholangiocarcinoma Detected by Butea monosperma Agglutinin.
Journal: Molecules (Basel, Switzerland)
Published: April 03, 2021
FOXM1c is the predominant FOXM1 isoform expressed in cholangiocarcinoma that associated with metastatic potential and poor prognosis of patients.
Journal: Heliyon
Published: December 18, 2020
Last Updated: 09/26/2026